Blood GlucoseHyperglycemiaDiabetes Mellitus, ExperimentalHypoglycemic AgentsInsulinGlucoseBlood Glucose Self-MonitoringGlucose Tolerance TestHypertensionHypoglycemiaGlucose IntoleranceDiabetes Mellitus, Type 2Diabetes MellitusBlood PressureHemoglobin A, GlycosylatedGlucose OxidaseFastingGlucose Transporter Type 1Diabetes Mellitus, Type 1Glucose Transporter Type 4Risk FactorsGlucagonPostprandial PeriodTime FactorsObesityDiagnostic EquipmentGluconeogenesisDeoxyglucoseMonosaccharide Transport ProteinsIslets of LangerhansBody WeightGlucose Transporter Type 2GlycosuriaGlucose 1-DehydrogenaseGlycogenPrevalenceAntihypertensive AgentsInsulin Infusion SystemsLiverDietary CarbohydratesBody Mass IndexCross-Sectional StudiesStreptozocinLactatesGlucokinaseMetabolic Syndrome XLactic AcidGlucose Transporter Type 3Blood Pressure DeterminationInsulin-Secreting CellsHomeostasisFatty Acids, NonesterifiedC-PeptideLipidsRats, WistarGlycemic IndexFructoseDiabetes ComplicationsReagent StripsGlucagon-Like Peptide 1Cardiovascular DiseasesTriglyceridesGlucose Metabolism DisordersGlycolysisReference ValuesLiver GlycogenDiabetic DietGlucose-6-PhosphateGlucose-6-PhosphataseMonitoring, PhysiologicPhlorhizinGlucose DehydrogenasesHexokinaseHyperinsulinismRats, Sprague-DawleyProspective StudiesMonitoring, AmbulatoryTreatment OutcomeFructosamineEnergy MetabolismAge FactorsSex FactorsPancreas, ArtificialFollow-Up StudiesBiological TransportEatingLife StyleCholesterolPlant ExtractsPrediabetic StateInsulin LisproGlucosephosphatesMuscle, SkeletalInsulin ResistanceCross-Over StudiesCohort StudiesDose-Response Relationship, DrugGlycerol3-O-MethylglucoseUnited States